Valuation : Phosphagenics Limited

Market Cap 85M 60.82M 52.46M 49.35M 44.96M 84.54M 5.77B 583M 227M 2.94B 228M 223M 9.74B P/E 2024
-2.5x
P/E 2025 -6.43x
Enterprise Value 80.35M 57.49M 49.59M 46.65M 42.5M 79.92M 5.46B 552M 215M 2.78B 216M 211M 9.2B EV / Sales 2024
5.85x
EV / Sales 2025 23x
Free-Float
76.76%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2020-04-30
Director of Finance/CFO 53 2018-12-27
Chief Operating Officer - 2020-04-30
Director TitleAgeSince
Director/Board Member - 2015-04-12
Chairman - 2018-12-31
Director/Board Member 59 2024-04-25
Change 5-day change 1-year change 3-year change Capi.($)
-14.29%-14.29% - - 63.64M
+0.43%-5.58%+58.44%+109.08% 1,031B
+1.34%-1.35%+51.33%+67.90% 641B
+1.28%-2.34%+22.49%+75.16% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+0.86%-2.21%+50.72%+68.46% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+1.49%-0.23%+31.69%+93.64% 181B
Average -0.47%-2.98%+28.74%+50.19% 403.31B
Weighted average by Cap. +0.95%-3.97%+37.82%+66.18%

Financials

2024 2025
Net sales 1.13M 810K 699K 658K 599K 1.13M 76.92M 7.77M 3.03M 39.13M 3.04M 2.98M 130M 1.24M 886K 764K 719K 655K 1.23M 84.05M 8.5M 3.31M 42.76M 3.33M 3.25M 142M
Net income -3.12M -2.23M -1.93M -1.81M -1.65M -3.11M -212M -21.43M -8.34M -108M -8.39M -8.21M -358M -4.42M -3.16M -2.73M -2.56M -2.34M -4.39M -300M -30.31M -11.8M -153M -11.86M -11.61M -506M
Net Debt -1.3M -929K -801K -754K -686K -1.29M -88.13M -8.91M -3.47M -44.83M -3.49M -3.41M -149M -4.65M -3.33M -2.87M -2.7M -2.46M -4.62M -316M -31.91M -12.42M -161M -12.49M -12.22M -532M
Logo Phosphagenics Limited
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Employees
-